Trials / Completed
CompletedNCT02396199
Zenith® p-Branch® Endovascular Graft Pivotal Study
Zenith® p-Branch® Pivotal Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Cook Research Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Zenith® p-Branch® Pivotal Study is a clinical trial approved by FDA to study the safety and effectiveness of the Zenith® p-Branch® endovascular graft in combination with the Atrium iCAST™ covered stents in the treatment of abdominal aortic aneurysms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Zenith® p-Branch® in combination with the Atrium iCAST™ covered stents | Instead of making a large incision in the abdomen, the physician makes a small incision near each hip to insert, and guides the study device(s) into place in the aorta. |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2021-04-01
- Completion
- 2025-01-28
- First posted
- 2015-03-24
- Last updated
- 2025-02-19
- Results posted
- 2022-10-25
Locations
27 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02396199. Inclusion in this directory is not an endorsement.